Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;54 Suppl 4(Suppl 4):S317-9.
doi: 10.1093/cid/cir988.

Surveillance of transmitted drug-resistant HIV among young pregnant women in Ouagadougou, Burkina Faso

Antoine Somda  1 , Lassana Sangare, Monique Soro, Saydou Yameogo, Babou Bazie, Françoise Bigirimana, Silvia Bertagnolio, Martine Peeters, Fatima Mouacha, Ana Maria Rivera, Michael R Jordan, Marie-Joseph Sanou
Affiliations

Surveillance of transmitted drug-resistant HIV among young pregnant women in Ouagadougou, Burkina Faso

Antoine Somda et al. Clin Infect Dis. 2012 May.

Abstract

Burkina Faso began rapid antiretroviral therapy (ART) scale-up in 2003 and by December 2009, 26,448 individuals were on treatment. With rapid scale-up of ART, some degree of human immunodeficiency virus transmitted drug resistance (TDR) is inevitable. Following World Health Organization methods, between June 2008 and July 2009, Burkina Faso assessed TDR in primigravid pregnant women aged <25 years attending antenatal care clinics in Ouagadougou, Burkina Faso. TDR was classified as moderate (5%-15%) for both nucleoside reverse-transcriptase inhibitors and nonnucleoside reverse-transcriptase inhibitors. The observed moderate TDR in Ouagadougou is a cause for concern and calls for closer monitoring of Burkina Faso's ART program.

PubMed Disclaimer

References

    1. Joint United Nations Program on HIV/AIDS. UNAIDS report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS; 2010. Available at: http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_.... Accessed 15 July 2011.
    1. World Health Organization, Joint United Nations Program on HIV/AIDS, UNICEF. Towards Universal Access: scaling up priority HIV/AIDS interventions in the health sector. Geneva: World Health Organization; 2010. Available at: http://www.who.int/hiv/pub/2010progressreport/en/index.html. Accessed 15 July 2011.
    1. Bennett DE, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 2008;13(Suppl 2):1–13. - PubMed
    1. Bennett DE, Myatt M, Bertagnolio, Sutherland D, Gilks CF. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther. 2008;13(Suppl 2):25–36. - PubMed
    1. Jordan MR, Bennett DE, Bertagnolio S, Gilks CF, Sutherland D. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites. Antivir Ther. 2008;13(Suppl 2):15–23. - PubMed

Publication types

Substances